Kyle Fitzgibbon

Clinical Research Coordinator I, BSc., MSc.

Kyle Fitzgibbon is a part of Dr. Gary Rodin’s team, serving as a Clinical Research Coordinator I. In his role, he oversees the implementation and daily operations of two large CIHR funded studies. The first is the Will to Live II (WTL-II) study, which is a longitudinal mixed-methods study that seeks to understand the prevalence, predictors and trajectories of psychological distress, disease burden and other factors that influence the desire for death and requests for medical assistance in dying (MAiD). The other is the Emotion and Symptom Focused Engagement (EASE) Phase III, multi-site, randomized control trial evaluating an early palliative care and psychosocial intervention versus usual care for patients with acute leukemia.

Kyle attended McMaster University and graduated with Bachelor of Science in Biology & Psychology and then went on to the University of Toronto where he graduated with a Master of Science in Health Services Research from the Institute of Health Policy, Management & Evaluation at the Dalla Lana School of Public Health.